Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
REVENUE	$ 3,266,846	$ 2,891,297	$ 6,468,589	$ 5,912,062
Cost of Revenue	807,672	892,019	1,646,247	1,996,080
GROSS PROFIT	2,459,174	1,999,278	4,822,342	3,915,982
OPERATING EXPENSES
Selling, general and administrative expenses	2,248,864	3,487,331	5,214,983	7,007,546
Research and development expenses	517,982	697,620	1,031,877	1,410,595
TOTAL OPERATING EXPENSES	2,766,846	4,184,951	6,246,860	8,418,141
LOSS FROM OPERATIONS	(307,672)	(2,185,673)	(1,424,518)	(4,502,159)
Interest expense	(752,075)	(753,268)	(1,520,748)	(1,413,780)
Accretion and amortization expenses [Note 5,6]	(339,888)	(596,420)	(1,484,616)	(1,153,639)
Change in fair value of derivative liabilities [Note 8]	(193,757)	(18,783)	(500,619)	82,669
Gain (loss) upon convertible promissory notes conversion and redemption [Note 9]	(4,690)	6,684	(132,301)	13,132
Other income (expense) [Note 9]	36,314	(143,380)	(193,486)	(129,945)
NET LOSS BEFORE INCOME TAXES	(1,561,768)	(3,690,840)	(5,256,288)	(7,103,722)
Income taxes [Note 3]
NET LOSS BEFORE DIVIDENDS	(1,561,768)	(3,690,840)	(5,256,288)	(7,103,722)
Preferred Stock Dividends	(91,261)	(190,442)	(290,353)	(379,139)
Deemed Dividends [Note 9]			(3,054,680)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	(1,653,029)	(3,881,282)	(8,601,321)	(7,482,861)
Translation adjustment	(129,376)	281,240	(105,793)	105,410
COMPREHENSIVE LOSS	$ (1,782,405)	$ (3,600,042)	$ (8,707,114)	$ (7,377,451)
LOSS PER SHARE, BASIC	$ (0.073)	$ (0.441)	$ (0.469)	$ (0.853)
LOSS PER SHARE, DILUTED	$ (0.073)	$ (0.441)	$ (0.469)	$ (0.853)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC	22,493,626	8,795,742	18,354,277	8,774,242
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED	22,493,626	8,795,742	18,354,277	8,774,242